基本信息
views: 390
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Current Research and Scholarly Interests
My research interests include phase I/II clinical trial evaluation of novel therapies for the following diseases:
--Myelodysplastic syndromes (MDS)
--Chronic myelogenous leukemia (CML)
--Acute myelogenous leukemia (AML)
--Myeloproliferative disorders (MPDs) including:
Hypereosinophilic syndrome
Systemic mastocytosis
BCR-ABL-negative MPDs
My research interests include phase I/II clinical trial evaluation of novel therapies for the following diseases:
--Myelodysplastic syndromes (MDS)
--Chronic myelogenous leukemia (CML)
--Acute myelogenous leukemia (AML)
--Myeloproliferative disorders (MPDs) including:
Hypereosinophilic syndrome
Systemic mastocytosis
BCR-ABL-negative MPDs
Research Interests
Papers共 588 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Jason Gotlib,Aaron T Gerds, Peter Abdelmessieh,Haris Ali,Mariana Castells,Andrew Dunbar, Ruth Fein Revell,Tracy I George, Steven Green,Krishna Gundabolu,Elizabeth Hexner,Tania Jain,
Journal of the National Comprehensive Cancer Network : JNCCNno. 2D (2024)
Journal of Allergy and Clinical Immunologyno. 2 (2024): AB238
Journal of Allergy and Clinical Immunologyno. 2 (2024): AB225
The New England journal of medicineno. 8 (2024): 723-735
The journal of allergy and clinical immunology. In practiceno. 10 (2023): 3010-3020
crossref(2023)
JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023): 7017-7017
Load More
Author Statistics
#Papers: 595
#Citation: 24822
H-Index: 73
G-Index: 148
Sociability: 8
Diversity: 3
Activity: 126
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn